Explore
Validate
LearnMAB5009
antibody from Abnova Corporation
Targeting: CD59
16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB5009 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#MAB5009, RRID:AB_10628803
- Product name
- CD59 monoclonal antibody, clone MEM-43 (Biotin)
- Antibody type
- Monoclonal
- Description
- Mouse monoclonal antibody raised against native CD59.
- Conjugate
- Biotin
- Isotype
- IgG
- Antibody clone number
- MEM-43
- Storage
- Store at 4°C. Do not freeze.Aliquot to avoid repeated freezing and thawing.
Submitted references Expression of glycosylphosphatidylinositol-anchored CD59 on target cells enhances human NK cell-mediated cytotoxicity.
Incorporation of leucocyte GPI-anchored proteins and protein tyrosine kinases into lipid-rich membrane domains of COS-7 cells.
Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59.
Omidvar N, Wang EC, Brennan P, Longhi MP, Smith RA, Morgan BP
Journal of immunology (Baltimore, Md. : 1950) 2006 Mar 1;176(5):2915-23
Journal of immunology (Baltimore, Md. : 1950) 2006 Mar 1;176(5):2915-23
Incorporation of leucocyte GPI-anchored proteins and protein tyrosine kinases into lipid-rich membrane domains of COS-7 cells.
Cebecauer M, Cerný J, Horejsí V
Biochemical and biophysical research communications 1998 Feb 24;243(3):706-10
Biochemical and biophysical research communications 1998 Feb 24;243(3):706-10
Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59.
Bodian DL, Davis SJ, Morgan BP, Rushmere NK
The Journal of experimental medicine 1997 Feb 3;185(3):507-16
The Journal of experimental medicine 1997 Feb 3;185(3):507-16
No comments: Submit comment
No validations: Submit validation data